Helena Odenstedt Hergès

Helena Odenstedt Hergès

Auto-generated profile, based on publicly available information

Helena Odenstedt Hergès

Department of Anaesthesiology and Intensive Care, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2005 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
HOHelena Odenstedt
Helena Odenstedt
SLSophie Lindgren
Sophie Lindgren
COCecilia Olegård
Cecilia Olegård
KEKarin Erlandsson
Karin Erlandsson
SLSven Lethvall
Sven Lethvall
SLStefan Lundin
Stefan Lundin

11 June 2018 in Neurocritical Care
Verified
Journal Article
Open access
PDF file
ENErik Norberg
Erik Norberg
HOHelena Odenstedt-Herges
Helena Odenstedt-Herges
BRBertil Rydenhag
Bertil Rydenhag
JOJonatan Oras
Jonatan Oras
Background Cardiac complications frequently occur after subarachnoid hemorrhage (SAH) and are associated with an increased risk of neurological complications and poor outcomes. The aim of this study was to evaluate the impact of acute cardiac complications after SAH on long-term mortality and cardiovascular events. Methods All patients admitted to our Neuro intensive care unit with verified SAH from January 2010 to April 2015, and electrocardiogram, echocardiogram, and troponin T or NTproBNP data obtained within 72 h of admission were included in the study. Mortality data were obtained from the Swedish population register. Data regarding cause of death and hospitalization for cardiovascular events were obtained from the Swedish Board of Health and Welfare. Results A total of 455 patients were included in the study analysis. There were 102 deaths during the study period. Cardiac troponin release (HR 1.08, CI 1.02–1.15 per 100 ng/l, p = 0.019), NTproBNP (HR 1.05, CI 1.01–1.09 per 1000 ng/l, p = 0.018), and ST-T abnormalities (HR 1.53, CI 1.02–2.29, p = 0.040) were independently associated with an increased risk of death. However, these associations were significant only during the first 3 months after the hemorrhage. Cardiac events were observed in 25 patients, and cerebrovascular events were observed in 62 patients during the study period. ST-T abnormalities were independently associated with an increased risk of cardiac events (HR 5.52, CI 2.07–14.7, p < 0.001), and stress cardiomyopathy was independently associated with an increased risk of cerebrovascular events (HR 3.65, CI 1.55–8.58, p = 0.003). Conclusion Cardiac complications after SAH are associated with an increased risk of short-term death. Patients with electrocardiogram abnormalities and stress cardiomyopathy need appropriate follow-up for the identification of cardiac disease or risk factors for cardiovascular disease.

7 September 2011 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LSL. Sand
L. Sand
MRM. Rizell
M. Rizell
EHE. Houltz
E. Houltz
KKK. Karlsen
K. Karlsen
JWJ. Wiklund
J. Wiklund
SLS. Lundin
S. Lundin

18 July 2022 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
SWSandra Bjerkne Wenneberg
Sandra Bjerkne Wenneberg
LBLinda Block
Linda Block
ASAnn Sörbo
Ann Sörbo
SNSilvana Naredi
Silvana Naredi
JOJonatan Oras
Jonatan Oras
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
Objectives The survival rates for patients affected by aneurysmal subarachnoid hemorrhage (aSAH) have increased in recent years; however, many patients continue to develop cognitive dysfunctions that affect their quality of life. The commonly used outcome measures often fail to identify these cognitive dysfunctions. This study aimed to evaluate the long-term outcomes at 1 and 3 years after aSAH to assess changes over time and relate outcomes to patient characteristics and events during the acute phase. Materials and Methods This prospective observational study included patients that experienced aSAH. Patients were assessed according to the extended Glasgow Outcome Scale, Life Satisfaction Questionnaire, Mayo-Portland Adaptability inventory-4, and Mental Fatigue scale. Results Patients were assessed after 1 year (n = 62) and 3 years (n = 54). At 3 years, the extended Glasgow Outcome Scale score improved in 15% and worsened in 12% of the patients. Mental fatigue was observed in 57% of the patients at 1 year. Patients <60 years of age at the time of aSAH had more self-assessed problems, including pain/headache (p < .01), than patients >60 years of age. Patients with delayed cerebral ischemia during the acute phase reported more dissatisfaction at 3 years, whereas no significant result was seen at 1 year. Conclusions Cognitive dysfunction, especially mental fatigue, is common in patients with aSAH, which affects quality of life and recovery. Patient outcome is a dynamic process developing throughout years after aSAH, involving both improvement and deterioration. This study indicates the importance of longer follow-up periods with broad outcome assessments.

13 June 2019 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LBLinda Block
Linda Block
MPMax Petzold
Max Petzold
ASAlma Nordenskjöld Syrous
Alma Nordenskjöld Syrous
BLBirgitta Lindqvist
Birgitta Lindqvist
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
SNSilvana Naredi
Silvana Naredi

31 March 2020 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
PDF file
SWSandra Bjerkne Wenneberg
Sandra Bjerkne Wenneberg
PHPia M. Löwhagen Hendén
Pia M. Löwhagen Hendén
JOJonatan Oras
Jonatan Oras
SNSilvana Naredi
Silvana Naredi
LBLinda Block
Linda Block
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
Background: Delayed cerebral ischemia (DCI) is a major cause of impaired outcome after aneurysmal subarachnoidal hemorrhage (aSAH). In this observational cohort study we investigated whether changes in heart rate variability (HRV) that precede DCI could be detected.Methods: Sixty‐four patients with aSAH were included. HRV data were collected for up to 10 days and analyzed offline. Correlation with clinical status and/or radiologic findings was investigated. A linear mixed model was used for the evaluation of HRV parameters over time in patients with and without DCI. Extended Glasgow outcome scale score was assessed after 1 year.Results: In 55 patients HRV data could be analyzed. Fifteen patients developed DCI. No changes in HRV parameters were observed 24 hours before onset of DCI. Mean of the HRV parameters in the first 48 hours did not correlate with the development of DCI. Low/high frequency (LF/HF) ratio increased more in patients developing DCI (β −0.07 (95% confidence interval, 0.12‐0.01); P = .012). Lower STDRR (standard deviation of RR intervals), RMSSD (root mean square of the successive differences between adjacent RR intervals), and total power (P = .003, P = .007 and P = .004 respectively) in the first 48 hours were seen in patients who died within 1 year.Conclusion: Impaired HRV correlated with 1‐year mortality and LF/HF ratio increased more in patients developing DCI. Even though DCI could not be detected by the intermittent analysis of HRV used in this study, continuous HRV monitoring may have potential in the detection of DCI after aSAH using different methods of analysis.